Latest Orthopaedic News & Breaking Orthopaedic News | Orthogate Professionals

New research from Royal Holloway, University of London has found that a new form of talking therapy is a credible and promising treatment for people with chronic low back pain who are also suffering from related psychological stress.

Professor Tamar Pincus from the Department of Psychology also found that patients preferred a combination of talking therapy and physiotherapy to address both the psychological and physical aspects of their back pain.

Osteoporosis is not the only potential target - scientists say aging, obesity and diabetes could be, too.

The researchers are from the Florida campus of The Scripps Research Institute, and they publish their work in the journal Nature Communications.

The study investigated a protein known as PPARG and examined its effect on bone marrowstem cells (mesenchymal stem cells).

With age, postmenopausal women with osteoporosis are at greater risk of losing their teeth. But what treatment for tooth loss provides women with the highest degree of satisfaction in their work and social lives?

A new study by Case Western Reserve University School of Dental Medicine researchers suggests dental implants may be the best route to take, according to Leena Palomo, associate professor of periodontics and corresponding author of "Dental Implant Supported Restorations Improve the Quality of Life in Osteoporotic Women."

Their findings were reported in the Journal of International Dentistry.

New findings provide opportunity for risk modification research

The results of a large population study presented today at the European League Against Rheumatism Annual Congress (EULAR 2015) showed an increased risk of developing Psoriatic Arthritis (PsA) among psoriasis patients exposed to physical trauma, particularly when the trauma involved bone and/or joints.

"This is the first sizable population-based cohort study to determine the risk of PsA following trauma in psoriasis patients," said Dr Thorvardur Love, senior author from Landspitali University Hospital, Iceland. "Our findings highlight the importance further study into the complex factors that lead to arthritis in psoriasis patients, as we may find ways to modify the risk once we fully understand it," he added.

Bristol-Myers Squibb Company has announced that data from the OrenciaPhase 3b AVERT and AMPLE trials will be presented in three separate posters during the European League Against Rheumatism Annual Congress (EULAR 2015). These trials included early moderate to severe rheumatoid arthritis (RA) patients with active disease and markers of poor prognosis, such as ACPA (anti-citrullinated protein antibody) and rheumatoid factor (RF), which are both associated with more severe disease progression and joint damage. These data suggest a correlation between ACPA and treatment outcomes, and provide further data regarding the use of Orencia plus methotrexate (MTX) in these RA patients.

Study shows 95 percent of children prefer 'This Feeling!' to conventional tools

The results of a study presented today at the European League Against Rheumatism Annual Congress (EULAR 2015) demonstrated the value of a new interactive iPad app that helps young people with Juvenile Idiopathic Arthritis (JIA) describe their pain. Almost all of the children preferred the new digital tool, aptly titled 'This Feeling', to other conventional methods and felt it was an interesting and engaging way to communicate about their experiences of pain.

"It is vital for children and young people to be able to communicate about their pain in order for them to access the best possible support to manage their condition long term," said Professor Wendy Thomson, Inflammatory Arthritis in Children Lead at the NIHR Manchester Musculoskeletal Biomedical Research Unit, UK.

The results of a study presented today at the European League Against Rheumatism Annual Congress (EULAR 2015) Press Conference showed that a diagnosis of ankylosing spondylitis (AS) can be predicted by low birth weight, having older siblings and hospitalisation for infection between the ages of 5-16 years. These data suggest that these factors play an important role in the pathogenesis of the disease.

AS is a painful and progressive form of arthritis caused by chronic inflammation of the joints in the spine.

Researchers have found a link between the amount of time teenage boys spend using screen-based media and reduced bone mineral density.

Anne Winther, of UiT The Arctic University of Norway in Tromsø, and colleagues publish their findings in the journal BMJ Open.

Using the intestinal hormone GLP-1 in obesity treatment prevents the loss of bone mass otherwise frequently associated with major weight loss. This is the finding of a new study from the University of Copenhagen, Hvidovre and Glostrup Hospital. According to the researchers behind the study, the results may have a significant bearing on future obesity treatment.

Rapid weight loss leads to a loss of bone mass and an increased risk of bone fractures. New research shows that treating obesity with the GLP-1 hormone helps prevent loss of bone mass in addition to having a number of positive effects on the formation of new bone and on blood sugar levels.